Vedanta Biosciences, Inc.
5 clinical trials · Sponsor
◉ Watch Vedanta Biosciences, Inc.
| Record | Firm | Date |
|---|---|---|
| VE303 for Prevention of Recurrent Clostridioides Difficile Infection (NCT06237452) | Vedanta Biosciences, Inc. | 2024-05-20 |
| VE202 in Patients With Mild-to-Moderate Ulcerative Colitis (NCT05370885) | Vedanta Biosciences, Inc. | 2023-05-08 |
| Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection (NCT03788434) | Vedanta Biosciences, Inc. | 2019-02-08 |
| First-in-human Study of VE303 in Healthy Adult Volunteers (NCT04236778) | Vedanta Biosciences, Inc. | 2017-11-28 |
Track Vedanta Biosciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.